Evidence map›Paper›PMID 25616408›Full record

ReviewRNA biology2014

The identification and characterization of non-coding and coding RNAs and their modified nucleosides by mass spectrometry.

Kirk W Gaston, Patrick A Limbach

Open access · bronzeAbstract readReview
In one paragraph

Review in RNA biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Stress-induced modification ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Analysis of RNA and Its Modifications.Annual review of analytical chemistry (Palo Alto, Calif.) · 2024
    Review
  8. Phosphorothioate RNA Analysis by NETD Tandem Mass Spectrometry.Molecular & cellular proteomics : MCP · 2024
    Article
  9. Mapping mMethods and protocols · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Detection technologies for RNA modifications.Experimental & molecular medicine · 2022
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kirk W Gastona Rieveschl Laboratories for Mass Spectrometry; Department of Chemistry ; University of Cincinnati ; Cincinnati , OH USA.
Patrick A Limbach
Oncology Hematology Care · US

Funding

UPLC for Enhanced Mass Spectrometry of Modified RNAsR01GM058843 · NIGMS · UNIVERSITY OF CINCINNATI · PI LIMBACH, PATRICK A · 1999 to 2025
$5.1M
Acquisition of an LC Mass Spectrometer for Nucleic Acids ResearchS10RR027671 · NCRR · UNIVERSITY OF CINCINNATI · PI LIMBACH, PATRICK A · 2010 to 2010
$500k
Mass Spectrometry of Ribosomal RNA:Protein InteractionsR56GM058843 · NIGMS · UNIVERSITY OF CINCINNATI · PI LIMBACH, PATRICK A · 2009 to 2009
$330k
NCRR NIH HHS RR27671NCRR NIH HHS S10 RR027671NIGMS NIH HHS GM58843NIGMS NIH HHS R01 GM058843
6 · The paper itself

Abstract

The analysis of ribonucleic acids (RNA) by mass spectrometry has been a valuable analytical approach for more than 25 years. In fact, mass spectrometry has become a method of choice for the analysis of modified nucleosides from RNA isolated out of biological samples. This review summarizes recent progress that has been made in both nucleoside and oligonucleotide mass spectral analysis. Applications of mass spectrometry in the identification, characterization and quantification of modified nucleosides are discussed. At the oligonucleotide level, advances in modern mass spectrometry approaches combined with the standard RNA modification mapping protocol enable the characterization of RNAs of varying lengths ranging from low molecular weight short interfering RNAs (siRNAs) to the extremely large 23 S rRNAs. New variations and improvements to this protocol are reviewed, including top-down strategies, as these developments now enable qualitative and quantitative measurements of RNA modification patterns in a variety of biological systems.

Indexed as

RNA Processing, Post-TranscriptionalBase SequenceEscherichia coliMass SpectrometryMolecular Sequence DataNucleic Acid ConformationNucleosidesOligonucleotidesRNA, MessengerRNA, Ribosomal, 23SRNA, Small InterferingRNA, UntranslatedThermoplasmaNucleosidesOligonucleotidesRNA, MessengerRNA, Ribosomal, 23SRNA, Small InterferingRNA, Untranslatedbiological ribonucleic acidsLC-MS/MSMALDI-MS/MSmodified basesmodified RNARNA sequencingrRNAtandem mass spectrometrytRNA

Identifiers

PMID25616408
PMCPMC4615682
OpenAlexW1999421720

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.